F Gao Selected Research

idoxifene

2/2001	Endothelial protective and antishock effects of a selective estrogen receptor modulator in rats.
11/2000	Nitric oxide stimulatory and endothelial protective effects of idoxifene, a selective estrogen receptor modulator, in the splanchnic artery of the ovariectomized rat.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

F Gao Research Topics

Disease

32	Neoplasms (Cancer) 01/2024 - 07/2000
10	Reperfusion Injury 06/2017 - 07/2000
9	Body Weight (Weight, Body) 01/2021 - 05/2001
9	Ischemia 04/2019 - 10/2000
9	Hypertension (High Blood Pressure) 07/2018 - 08/2000
8	Breast Neoplasms (Breast Cancer) 01/2022 - 04/2001
8	Pain (Aches) 08/2019 - 12/2007
7	Inflammation (Inflammations) 12/2023 - 05/2001
7	Infections 05/2023 - 07/2000
7	Leukemia 01/2016 - 06/2000
6	Colorectal Neoplasms (Colorectal Cancer) 08/2022 - 11/2009
6	Infarction (Infarctions) 05/2015 - 10/2000
5	Hemorrhage 04/2024 - 01/2002
5	Necrosis 04/2020 - 02/2001
5	Retinal Degeneration 01/2017 - 03/2000
5	Myocardial Infarction 05/2015 - 10/2000
5	Myocardial Ischemia (Ischemic Heart Diseases) 05/2015 - 07/2000
4	Hepatocellular Carcinoma (Hepatoma) 01/2024 - 07/2000
4	Wounds and Injuries (Trauma) 07/2023 - 01/2008
4	Atherosclerosis 01/2020 - 01/2012
4	Alzheimer Disease (Alzheimer's Disease) 06/2014 - 01/2000
4	Acute Lung Injury 03/2013 - 02/2005
3	Thrombosis (Thrombus) 01/2024 - 10/2015
3	Colonic Neoplasms (Colon Cancer) 01/2023 - 10/2015
3	Non-Small-Cell Lung Carcinoma (Carcinoma, Non-Small Cell Lung) 01/2023 - 01/2013
3	Malnutrition (Nutritional Deficiencies) 11/2022 - 01/2001
3	Fatigue 01/2022 - 05/2010
3	Fibrosis (Cirrhosis) 03/2021 - 10/2001
3	Nasopharyngeal Carcinoma 10/2020 - 07/2003
3	Pathologic Constriction (Stenosis) 01/2020 - 06/2010
3	Stroke (Strokes) 01/2020 - 09/2001
3	Weight Loss (Weight Reduction) 08/2019 - 12/2014
3	Hypoxia (Hypoxemia) 11/2017 - 01/2015
3	Neuralgia (Stump Neuralgia) 05/2015 - 02/2012
3	Endometrial Neoplasms (Endometrial Cancer) 01/2015 - 11/2000
3	Nausea 01/2013 - 01/2010
3	Respiratory Distress Syndrome (Acute Respiratory Distress Syndrome) 03/2008 - 02/2005
3	Amyloid Plaque 09/2001 - 01/2000
2	Diarrhea 04/2024 - 01/2013
2	Fever (Fevers) 01/2024 - 09/2016
2	Abdominal Pain (Pain, Abdominal) 01/2024 - 01/2010
2	Atrophy 02/2023 - 06/2018
2	Rectal Neoplasms (Rectal Cancer) 01/2023 - 07/2010
2	Aortic Valve Insufficiency (Aortic Regurgitation) 02/2021 - 01/2021
2	Asthma (Bronchial Asthma) 01/2021 - 01/2020
2	Disease Progression 08/2020 - 04/2007
2	Uveitis 03/2020 - 11/2018

Drug/Important Bio-Agent (IBA)

12	Proteins (Proteins, Gene)FDA Link 01/2021 - 02/2000
8	AntibodiesIBA 07/2021 - 06/2000
6	Glucose (Dextrose)FDA LinkGeneric 01/2021 - 11/2004
6	Interleukin-6 (Interleukin 6)IBA 08/2020 - 08/2001
6	AntioxidantsIBA 04/2020 - 10/2000
5	Biomarkers (Surrogate Marker)IBA 01/2021 - 06/2014
5	DNA (Deoxyribonucleic Acid)IBA 01/2020 - 11/2004
5	Methotrexate (Mexate)FDA LinkGeneric 01/2003 - 08/2000
4	Small Interfering RNA (siRNA)IBA 02/2021 - 05/2015
4	Messenger RNA (mRNA)IBA 04/2020 - 02/2005
4	Phenobarbital (Luminal)FDA Link 04/2013 - 10/2001
4	Reduced Folate Carrier ProteinIBA 01/2003 - 06/2000
3	CollagenIBA 03/2021 - 09/2009
3	Peptides (Polypeptides)IBA 02/2021 - 07/2000
3	LipidsIBA 01/2021 - 01/2013
3	AlbuminsIBA 01/2021 - 01/2020
3	Long Noncoding RNAIBA 01/2021 - 01/2020
3	Amino Acids FDA Link 12/2020 - 08/2000
3	Interleukin-10 (Interleukin 10)IBA 08/2020 - 10/2010
3	Anti-Bacterial Agents (Antibiotics)IBA 03/2019 - 01/2004
3	LigandsIBA 01/2018 - 05/2002
3	P-SelectinIBA 06/2017 - 05/2002
3	Tumor Necrosis Factor-alpha (Tumor Necrosis Factor)IBA 06/2017 - 11/2000
3	CytokinesIBA 06/2017 - 08/2000
3	Estrogens (Estrogen)FDA Link 12/2016 - 11/2000
3	Monoclonal AntibodiesIBA 11/2016 - 06/2013
3	Neuroprotective AgentsIBA 01/2016 - 03/2000
3	Vascular Endothelial Growth Factor A (Vascular Endothelial Growth Factor)IBA 01/2016 - 02/2005
3	salicylhydroxamic acid (SHAM)IBA 02/2015 - 09/2001
3	Superoxide DismutaseIBA 01/2014 - 06/2011
3	Insulin (Novolin)FDA Link 01/2013 - 09/2004
3	Hyaluronic Acid (Hyaluronan)IBA 01/2008 - 02/2001
3	Nitric Oxide (Nitrogen Monoxide)FDA Link 09/2001 - 07/2000
2	Cisplatin (Platino)FDA LinkGeneric 12/2023 - 01/2020
2	Nucleic AcidsIBA 05/2023 - 04/2016
2	ErbB Receptors (EGF Receptor)IBA 01/2023 - 01/2013
2	RNA (Ribonucleic Acid)IBA 08/2022 - 08/2013
2	Transforming Growth Factor beta (TGF-beta)IBA 03/2021 - 01/2021
2	MicroRNAs (MicroRNA)IBA 01/2021 - 06/2016
2	fibrin fragment D (D-dimer)IBA 08/2020 - 01/2020
2	Taurine FDA Link 04/2020 - 02/2019
2	GlucocorticoidsIBA 03/2020 - 11/2018

Therapy/Procedure

24	Therapeutics 01/2024 - 11/2000
11	Drug Therapy (Chemotherapy) 01/2024 - 10/2008
8	Transplantation 01/2016 - 05/2002
6	Radiotherapy 01/2018 - 04/2002
4	Aftercare (After-Treatment) 01/2024 - 09/2016
3	Transcatheter Aortic Valve Replacement 02/2021 - 01/2021
3	Hematopoietic Stem Cell Transplantation 06/2020 - 10/2016
3	Stents 01/2020 - 06/2010
3	Liver Transplantation 06/2017 - 11/2007
3	Immunotherapy 11/2016 - 07/2000
2	Radiofrequency Ablation 08/2022 - 09/2016